Skip to main content
. 2018 Nov 14;24:8190–8197. doi: 10.12659/MSM.912643

Figure 3.

Figure 3

Immunostaining of KIF22 in prostate cancer and adjacent benign prostate tissues. (A) Immunostaining showed positive KIF22 in cytoplasm of prostate cancer cells. (B) Immunostaining showed negative KIF22 in prostate cancer tissues. (C) KIF22 was negative or weakly expressed in adjacent benign prostate tissues.